Biodegradable hollow fibres for the controlled release of hormones by Eenink, M.J.D. et al.
Journal of Controlled Release, 6 (1987) 225-247 
Elsevier Science Publishers B.V., Amsterdam - Printed in The Netherlands 
225 
BIODEGRADABLE HOLLOW FIBRES FOR THE CONTROLLED RELEASE OF 
HORMONES* 
M.J.D. Eenink and J. Feijen** 
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J. Olijslager, J.H.M. Albers, J.C. Rieke and P.J. Greidanus 
The Plastic and Rubber Research Institute TNO, P. 0. Box 7 1, 2600 AB Delft (The Netherlands) 
Poly(&actide), (PLLA), hollow fibres were prepared using a dry-wet phase inversion spinning 
process. The effect of several spinning parameters (i.e. bore medium flow rate, spinning dope 
extrusion rate, fibre take-up rate, and spinning height) on the hollow fibre dimensions is reported. 
The use of several spinning systems (i.e. different solvent/non-solvent pairs with or without 
additive) resulted in PLLA hollow fibres with varying asymmetric membrane structures, i.e. a 
porous matrix covered by an internal and external skin varying from very thick and dense to very 
thin and porous. Some of the differences in membrane structure were qualitatively explained on 
the basis of a model developed by Reuvers [52] for the formation of flat-sheet membranes by 
immersion precipitation. Release experiments were carried out using PLLA hollow fibres filled 
with a 25 wt.% dispersion of micronized 3H-levonorgestrel in castor oil, and a receiving fluid 
consisting of 40 wt.% aqueous ethanol. The hollow fibre levonorgestrel release rates were found 
to be dependent on the membrane structure of the hollow fibre wall. For the different hollow fibre 
samples, zero-order levonorgestrel release rates were found, in the range of 0.1-10 ug/cm/day. 
Possible release mechanisms are discussed. Preliminary in vivo (rabbit) release experiments 
showed that constant levonorgestrel blood plasma levels could be obtained for a period up to 210 
days. It is concluded that the new biodegradable hollow fibre reservoir device shows very prom- 
ising properties for possible application as a long-acting contraceptive delivery system. 
INTRODUCTION 
The development of biodegradable drug 
delivery systems has received considerable 
attention during the last decade (reviews 
[l-8] ). To achieve a zero-order drug release 
rate, reservoir devices may be used, provided 
that the activity of the drug in the reservoir 
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remains constant and the polymeric membrane 
remains intact during drug delivery [g-12,13]. 
Biodegradable reservoir devices currently 
investigated include: (a) polyester microcap- 
sules, prepared from L-lactide and D,L-lactide 
homopolymers or their copolymers with glycol- 
ide either by a coacervation [ 14-161 or an air 
suspension coatingprocess [ 17,181; (b) poly (cy- 
amino acid) macrocapsules, prepared from L- 
glutamic acid/y-ethyl-L-glutamate copolymers 
by a dip-coating technique [ 19-211; (c) polyes- 
ter macrocapsules, prepared from poly ( e-cap- 
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rolactone) by polymer melt extrusion [ 22-241 
and (d) polymer coating and drug containing 
core, usually employing poly ( e-caprolactone ) 
containing dispersed drug as the core material 
with various biodegradable (co)polymers as the 
surrounding wall [ 25,261. 
The systems mentioned above have some 
drawbacks such as not being removable in case 
of complications during treatment (a), require 
surgery or a large injection device (b, c ) , require 
the use of highly permeable polymers (b, c, d) , 
are less suitable for polymers with low thermal 
stability (c, d) or require compatibility of the 
drug with the production process (a, d) . 
In this paper we will describe the develop- 
ment and characterization of a reservoir device 
based on biodegradable hollow fibres, which 
might overcome the limitations discussed above. 
The hollow fibers (diameter up to 1.5 mm and 
length up to 3 cm) are made of poly (L-lactide) , 
PLLA using a phase inversion spinning pro- 
cess. Fibers with these dimensions can be 
applied subdermally with a simple injection 
device and are still large enough to allow 
removal by minor surgery when necessary. 
Using PLLA hollow fibres a sustained zero- 
order drug release-rate may be obtained because 
PLLA has a relatively low rate of biodegrada- 
tion [ 27-291. PLLA also has a low permeabil- 
ity for drugs [ 2,6,25,30] and a low thermal 
stability [ 31-331. Application of the phase- 
inversion spinning process allows the prepara- 
tion of asymmetric membranes with a reduced 
resistance for drug permeation. Furthermore 
the fabrication process is carried out at low 
temperatures thus preventing degradation of 
PLLA. Because the hollow fibres can be filled 
with drug after the spinning procedure, the pro- 
duction process is highly drug compatible. 
Currently biodegradable polymeric rods or 
capsules [ 2,34-371 and intramuscular injecta- 
bles based on biodegradable polymeric micro- 
capsules [ 171 or microspheres [ 30,381 are being 
developed as long acting contraceptives. Only 
the injectable microspheres based on a copoly- 
mer of D,L-lactide and glycolide (85/15) 
designed to deliver the progestin norethindrone 
for 3 months [ 391 and the subdermal implant 
Capronor @ , consisting of a poly ( e-caprolac- 
tone) capsule filled with a dispersion of levo- 
norgestrel in ethyl oleate and designed to release 
the steroid for a period up to one year [ 231 have 
reached the stage of human clinical trials. 
Although devices based on biodegradable 
microspheres (and microcapsules) have the 
advantage of being injectable and easily admin- 
istered [ 391 an important limitation men- 
tioned by several investigators [ 1,6,40] is their 
lack of reversibility without extensive surgical 
intervention. 
The Capronor@ device is a reversible system, 
but requires surgical implantation under local 
anesthesia involving incision of the skin and 
insertion of the capsule through an 11-gauge 
needle using a trocar [ 231. The dimensions of 
the Capronor@ device, which contains a non- 
porous homogeneous capsule wall, are dictated 
by the desired steroid release rate and duration 
of action. 
The biodegradable hollow fibre concept how- 
ever aiming at a device with relatively small 
dimensions, possibly could result in a contra- 
ceptive delivery system which combines revers- 
ibility with subdermal injectability, thereby 
obviating the need for surgical implantation. 
The in vitro and in uiuo release of the contra- 
ceptive hormone levonorgestrel from PLLA 
hollow fibres prepared under different spinning 
conditions will also be discussed in this paper. 
MATERIALS AND METHODS 
Materials 
Chloroform, dichloromethane, 1,4-dioxane 
and N-methyl-2-pyrrolidone (NMP) were of 
analytical grade. Ethanol and methanol were 
chemically pure. L-lactide was purchased from 
C.C.A. Biochem, Gorinchem, The Netherlands 
and was stored at - 20°C in a dry nitrogen 
atmosphere. Stannous octoate (tin (II) -2- 
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ethylhexanoate) was obtained from Alpha 
Products, Danvers, MA 01923, U.S.A., and kept 
at room temperature under a dry nitrogen 
atmosphere. Poly ( N-vinylpyrrolidone) , PVP 
K-15, I&= lo4 was obtained from GAF Cor- 
poration, Schiedam, The Netherlands. Tritium 
labeled and non-radiolabeled micronized 
( < 3~) levonorgestrel was obtained as a gift 
from Schering A.G., Berlin, Germany. The tri- 
tium-labeled ( 15,16-3H) levonorgestrel had a 
specific activity of 0.25 mCi/g (5.50X 10’ 
dpm/g, or 9.17 MBq/g). Castor oil (Ph.Eur.) 
was purchased from Serva, Heidelberg, 
Germany. 
Poly ( L-lactide ) , PLLA, was synthesized at 
T= 130’ C by bulk ring-opening polymeriza- 
tion of L-lactide using stannous octoate as ini- 
tiator [ 411. Two batches of PLLA were 
prepared: PLLA-1 (600 g), monomer to initi- 
ator (M/I) molar ratio 150, [ ~1 = 2.4 dl.g-’ 
(25°C CHC13), a,= 1.3 x 105, M,= 1.5x 105, 
&=9.5x 104; PLLA-2 (1 kg), M/1=5x 104, 
[q] =6.3dl.g-’ (25”C,CHC1,),M,=4.75x105. 
Methods 
Infrared spectra were recorded on a Beck- 
man IR-33 Infrared Spectrophotometer. Sam- 
ples from the PLLA hollow fibres were prepared 
by casting thin films from chloroform solu- 
tions. ‘H-NMR spectra were recorded on a 
Nicolet 200 MHz NMR apparatus at ambient 
temperature using CDC13 as solvent and tetra- 
methylsilane (TMS) as internal reference. UV 
spectra were recorded on a Unicam SD 800 UV 
Spectrophotometer. UV extinctions were 
measured using a Zeiss Spektral Photometer 
PM-6. 
Polymer average molecular weights (%I,, 
Ii&) were determined by combined high per- 
formance gel permeation chromatography 
(GPC) and low angle laser light scattering 
(LALLS). The GPC unit, consisting of a 
Waters model 6000A HPLC pump and a Waters 
U6K injector, was equipped with a Styragel 
(Waters, 500 A; 37-75 flu) containing Waters 
guard column (cat. no. 84550) and four Waters 
$Styragel (106, 105, 104, lo3 A) GPC columns 
(7.8~300 mm) in series, and connected to a 
Chromatix KMX-6 LALLS apparatus (A= 633 
nm) and a Waters R401 differential refracto- 
meter. The overall column efficiency amounted 
to 20,000 theoretical plates. Elution was per- 
formed at room temperature at a flow rate of 
2.0 ml/min using dichloromethane (p.a.) as 
eluent. PLLA solutions in dichloromethane 
were filtered before use, using a Millipore Flu- 
oropore FHLP (0.5 ,u) filter. 
The refractive index increment (dn/dc) of 
PLLA in dichloromethane at 633 nm was deter- 
mined at room temperature using a Brice Phoe- 
nix BP-2000-V differential refractometer. For 
the two PLLA samples the same value of 
dn/dc = 0.032 ml/g was found, which was there- 
after taken as a constant independent of PLLA 
molecular weight. 
A correction of the LALLS data for the sec- 
ond virial coefficient was necessary and per- 
formed as indicated by Ouano [ 421. The second 
virial coefficient (determined by static LALLS 
measurements using the Chromatix KMX-6 
apparatus; see e.g. Ref. 43) was assumed to be 
0.003 mol.ml/g’ for the whole range of molec- 
ular weights investigated. Correct.ion for col- 
umn dispersion (band-broadening) was found 
not to be necessary, as was determined from the 
GPC-LALLS data of narrow-MWD polysty- 
rene standards (see also Refs. 42,44). 
PLLA intrinsic viscosities were determined 
at 25 ‘C in chloroform using an Ubbelohde cap- 
illary viscometer. PLLA viscosity average 
molecular weights (I?&) were calculated from a 
Mark-Houwink relationship established before 
[41]: 
[q] =3.48~10-~ I@?.” (dleg-‘). 
Differential scanning calorimetry (DSC) 
measurements were performed using a DuPont 
910 DSC apparatus equipped with a DuPont 
1090 Thermal Analyzer. The samples (ca. 2-5 
mg) were heated in sealed aluminium DSC pans 
at a scan speed of 5 ’ C/min. After the first scan 
Fig. 1 (a). Scheme of dry-wet spinning process: (A) bore 
injection liquid reservoir; (B) pump; (C) spinneret 
(enlarged) ; (D) spinning solution reservoir; (E) filter; (F) 
first coagulation bath; (G) second coagulation bath; (H) 
godet. 
Fig. 1 (b) . Tube-in-orifice spinneret nozzle cross-section: 
(A) spinning solution; (B) bore injection fluid (internal 
coagulant). 
(up to T = 200 ’ C ) , the samples were allowed to 
cool to room temperature and a second ther- 
mogram was recorded. The degree of crystallin- 
ity of the PLLA hollow fibres was calculated 
from the measured heat of fusion (AH, ) using 
the AH, value for fully crystalline PLLA, 
dH,=93.7 J/g, given by Fisher et al. [ 451. 
Melting points (T,) were taken as the peak 
melting temperatures. Glass transition temper- 
atures ( T,) were taken as the temperatures in 
the thermogram at the intersection of the 
extrapolation of the baseline with the extrapo- 
lation of the inflection. 
Preparation of hollow fibres 
The hollow fibre dry-wet phase inversion 
spinning process is schematically shown in Fig. 
la. The spinning dope (consisting of polymer, 
solvent and sometimes additive) was prepared 
directly in the spinning solution reservoir (D ) 
of 0.7 liter capacity (usually at T= 50°C ) . Part 
of the solution was temporarily removed to 
measure its viscosity (usually at T = 50’ C ) with 
a Brookfield Synchro-lectric viscometer (model 
RVT). The viscous spinning solution was 
degassed and pumped (Elmekanics rotary gear 
precision metering pump) from the reservoir 
(which was kept at 1 bar nitrogen overpres- 
sure ) through a heated tube (usually T = 50 ’ C ) 
via a ca. 40,~ cotton fabric filter (E; type KFW 
6156, Merrem and Laporte, Zaltbommel, The 
Netherlands) into the spinneret (C ) . 
The applied spinneret was a tube-in-orifice 
device (Fig. lb) with an orifice diameter of 1.0 
mm, an injection tube outside diameter of 0.6 
mm and an inside diameter of 0.4 mm. The con- 
tents of the spinneret were not heated, except 
when processing PLLA solutions in NMP 
(T=SO’C). The bore injection fluid (internal 
coagulant) was pumped (Perfusor@, Secura, 
Braun) from its reservoir (A) into the inner 
tube of the spinneret. The coagulation bath (F, 
external coagulant) was placed at a distance h 
under the spinneret. The length of the nascent 
fibre in the first coagulation bath (F) was 0.6 
m. The nascent hollow fibre was passed several 
times through a second coagulation bath (G) 
containing the same (external) coagulant, 
resulting in a total fibre length in the second 
bath of 8.4 m. Both coagulation baths (F, G) 
containing polymer non-solvent (i.e. water or 
methanol) were kept at room temperature. 
After passing through the second coagulation 
bath, the hollow fibre was transferred onto a 
self-advancing godet (H) . The godet speed 
determined the withdrawal rate of the yarn from 
the spinneret. The hollow fibre was collected 
and stored in a beaker with coagulant (water or 
methanol) for at least another day. The coag- 
ulant was refreshed several times. Finally, the 
bundles of hollow fibre were air dried. 
After spinning, the hollow fibres were char- 
acterized with respect to PLLA molecular 
weight (viscometry and GPC-LALLS) , resid- 
ual additive content (IR, ‘H-NMR), crystal- 
linity (DSC) , dimensions (light microscopy) 
229 
and membrane microstructure (SEM) . 
Hollow fibre dimensions (inner and outer 
diameter) were determined by analysis of their 
cross-section by light microscopy using a Nikon 
Labophot Light Microscope, equipped with a 
Hitachi CCTV camera (magnification: 50 x ) . 
The samples were prepared by cryogenic break- 
ing (in liquid nitrogen). 
To investigate the hollow fibre wall micro- 
structure, cross-sections of the hollow fibres 
were examined by scanning electron micros- 
copy (SEM) with a JEOL JSM 35 CF Scan- 
ning Electron Microscope. The samples were 
prepared by cryogenic grinding in liquid nitro- 
gen followed by coating with a charge conduct- 
ing layer of gold by means of a Balzer sputter 
unit. 
Preparation of hollow fibre samples for 
release experiments 
Hollow fibre samples were filled with a 25 
wt.% dispersion of micronized 3H-levonorges- 
trel in castor oil in the following manner: Pieces 
of hollow fibre were cut to the desired length 
(ca. 8 cm). To enable filling, both ends of each 
hollow fibre sample were first cemented into the 
lumen of a piece (ca. 1 cm) of silicone rubber 
( Silastic @ ) medical grade tubing ( Talas, 
Ommen, The Netherlands; type SR ZHH: 
di = 1.3 mm, d, = 2.5 mm ) using a RTV silicone 
rubber adhesive sealant (General Electric, 
Waterford, New York). The hollow fibre sam- 
ples were filled with the steroid dispersion using 
a syringe, which was introduced into the sili- 
cone rubber tubing. The filled hollow fibre was 
heat sealed at the desired length using a hot pair 
of pincers ( T- 140-150” C ) , after which the 
remaining pieces of fibre including the silicone 
rubber tubing were cut away from both ends. 
Determination of hollow fibre levonorgestrel 
content 
The initial hollow fibre levonorgestrel con- 
tent (expressed in ,ug steroid per cm hollow fibre 
TABLE 1 
Solubility of levonorgestrel in ethanol-water mixtures 
Ethanol/water Solubility” 
(w/w) (w/ml ) 
100/o 8.3 -8.6 
70/30 4.1 -4.5 
45/55 0.70-0.76 
40/60 0.35-0.40 
25115 0.19-0.23 
o/100 0.005b 
“at T=37"C, bRef. 46. 
length) was calculated from the total amount 
of radioactivity released from the hollow fibre 
during the in vitro release experiment, and the 
residual amount of radioactivity of the hollow 
fibre at the end of the release experiment (see 
below ) . 
For hollow fibres filled with a dispersion of 
non-radiolabeled levonorgestrel in castor oil, the 
initial steroid content (core load) was deter- 
mined by UV spectroscopy. A filled sample of 
the hollow fibre batch studied was dissolved in 
chloroform, and the amount of steroid deter- 
mined spectrophotometrically (A = 247 nm; 
E = 17.200 l/mol-cm) . 
Determination of levonorgestrel solubility 
Solubilities of levonorgestrel in castor oil and 
ethanol-water mixtures at T= 37°C were esti- 
mated by adding small known amounts of cas- 
tor oil (or ethanol-water mixture) to a 
suspension of solid (non-radiolabeled) levon- 
orgestrel in the same medium, until a clear 
solution was obtained. Between the castor oil 
(or ethanol-water) additions, the suspension 
was equilibrated for 24 hours at T = 37 ’ C in a 
shaking water bath. In this way, the solubility 
of levonorgestrel in castor oil was estimated to 
be in the range of 2.3-2.6 mg/ml. Solubilities of 
levonorgestrel in ethanol-water mixtures of 
various compositions are listed in Table 1. 
In vitro release of levonorgestrel 
The in vitro release of levonorgestrel from the 
hollow fibres was studied as follows: For each 
hollow fibre batch investigated, five filled hol- 
low fibre samples of known length (ca. 5 cm 
each) were immersed in separate glass vials 
containing (usually) 40 wt.% aqueous ethanol 
(EtOH/H,O : 40/60 w/w) as the receiving fluid 
(30 ml). The sealed vials were incubated at 
37” C and agitated in a shaking water bath 
(Kijttermann, Hanigsen, Germany; type 3047) 
at 135 cycles/min. Increasing the water bath 
shaking frequency to 190 cycles/min did not 
change the release rates. Periodically, aliquots 
( 200 ,ul ) were removed from the receiving fluid 
and assayed for 3H-levonorgestrel by liquid 
scintillation counting (10 min; LKB-Wallac 
1219 RackBeta Spectral Liquid Scintillation 
Counter, or Packard Tri-Carb Liquid Scintil- 
lation Spectrometer 3255). Lipoluma@ 
(Lumac, Schaesberg, The Netherlands), resp. 
Plasmasol@ (United Technologies Packard) 
were used as scintillation cocktail (4 ml). From 
the data of the five samples investigated for each 
hollow fibre batch, the average amount of 
levonorgestrel released was calculated. The 
receiving fluid of each vial was changed with 
such frequency that the concentration of levon- 
orgestrel in the receiving fluid was maintained 
below 2% of its solubility (“infinite sink” con- 
ditions) . At the end of the test period, the resid- 
ual levonorgestrel content of the hollow fibres 
was determined by dissolving the samples in 
dioxane ( 30 ml) and counting an aliquot ( 200 
~1) of this solution as described above. 
Sterilization of hollow fibres 
To study the effect of sterilization by gamma 
irradiation on the hollow fibre release proper- 
ties, some of the filled PLLA hollow fibres were 
exposed to a 2.5 MRad ( =25 kGy) dose of 
gamma radiation from a cobalt-60 source (per- 
formed at Gammaster, Ede, The Netherlands). 
A number of other PLLA hollow fibre samples 
from the same batch were exposed to gamma 
radiation (2.5 MRad) prior to filling with the 
steroid dispersion. 
Average PLLA molecular weights (%l,, @,) 
of the latter irradiated hollow fibre samples were 
determined by GPC-LALLS as described before 
and compared to the values of the non-irradi- 
ated samples. 
In viva release of levonorgestrel 
Preliminary in uiuo levonorgestrel release 
experiments in rabbits, sponsored by the WHO 
(World Health Organization, Geneva, Switz- 
erland) , were carried out under the supervision 
of Dr. H.L. Gabelnick at the National Institute 
of Child Health and Human Development 
(NICHD) , Bethesda, Maryland, U.S.A. In 
these experiments, two types of PLLA hollow 
fibres were used. The hollow fibres (length of 
each device: 3 cm), filled with a 25 wt.% dis- 
persion of micronized non-radiolabeled levon- 
orgestrel in castor oil, were implanted 
subcutaneously into the rabbit scapular region. 
Two (non-sterilized) devices of the same hol- 
low fibre type were implanted into each rabbit. 
Daily blood plasma levels of levonorgestrel were 
determined by a radioimmunoassay. 
RESULTS 
Preparation of poly(L-lactide) hollow fibres 
Several PLLA solvent/non-solvent pairs with 
or without additive in the spinning solution were 
used for spinning of PLLA hollow fibres. The 
different spinning systems investigated are 
summarized in Table 2. Polymer concentra- 
tions and temperatures of the spinning solu- 
tions were chosen to obtain spinning dope 
viscosities in the range of ~=200-1000 Poise 
(20-100 Pass). 
A PLLA concentration of 10 weight percent 
was regarded as the minimum polymer concen- 
tration necessary to obtain suitable hollow 
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fibres. Because of the very high viscosities of 
the PLLA-2 ( I’& = 475,000) dioxane and chlo- 
roform solutions (q> 5000 Poise for a 10 wt.% 
cont. at T= 50°C)) only NMP was used as the 
solvent for spinning of PLLA-2 hollow fibres. 
In this case, relatively high temperatures 
( T= 80’ C ) had to be used to dissolve PLLA, 
and heating of the spinneret was necessary to 
prevent premature precipitation of PLLA. Vis- 
cosity measurements showed that for the 
PLLA-1 (I&= 130,000) concentrations of 15 
wt.% PLLA could be used when operating at 
somewhat elevated temperatures (T = 
45-50°C) to yield spinning solution viscosities 
in the desired range. 
For practical reasons, water was chosen as the 
internal and external coagulant where possible, 
i.e. when using NMP or dioxane as the solvent. 
For the chloroform solutions, the external and 
the internal coagulant used were methanol and 
ethanol respectively. 
In addition to the spinning systems men- 
tioned above, PLLA hollow fibres were also 
prepared from dioxane and chloroform solu- 
tions containing low molecular weight poly (N- 
vinylpyrrolidone) as additive, PVP (&I,= 104), 
and from a dioxane solution containing L-lac- 
tide as additive. 
TABLE 2 
Hollow fibre spinning systems investigated 
Effect of spinning conditions on hollow fibre 
dimensions 
The effect of several spinning conditions on 
PLLA hollow fibre dimensions was investi- 
gated by determining the inside (di) and out- 
side diameter (d,), and thereby the wall 
thickness (cl,), by light microscopic analysis of 
the hollow fibre cross-sections. The spinning 
parameters investigated for each spinning sys- 
tem included the flow rate of the internal coag- 
ulant (bore medium) and the spinneret 
distance from the coagulation bath (spinning 
height). For some spinning systems, the flow 
rate of the spinning solution (extrusion rate) 
and the fibre withdrawal rate from the spin- 
neret (take-up rate) was varied in addition. 
Typical results for the spinning systems H-146 
and H-148 (see Table 2) are summarized in 
Tables 3 and 4. For the other spinning systems, 
similar results were found. The results show 
that PLLA hollow fibres with outside diame- 
ters in the range of do=6004320 pm, inside 
diameters in the range of di = 445-640 pm, and 
wall thicknesses in the range of d, = 60-125 ,um 
were obtained. 
From the results given in Tables 3 and 4 the 
following trends appear. With increasing bore 
medium (internal coagulant) flow rate, an 
increase of the hollow fibre inside and outside 
diameter was found, independent of the partic- 
System 
polymer code 
H-144 PLLA-2 
H-145 PLLA-1 
H-147 PLLA-1 
H-142 PLLA-1 
H-146 PLLA-1 
H-148 PLLA-1 
Spinning dope Temperature rf 
(“C) (Poise) 
Components cont./ (wt.% ) 
PLLA/NMP 10/90 80 1800b 
PLLA/dioxane 15/85 50 400 
PLLA/CHCl, 14/86 45 1000 
PLLA/Lact/dioxane’ 15/5/80 50 315 
PLLA/PVP/dioxane 15/5/80 50 285 
PLLA/PVP/CHCl, 14/4.7/81.3 45 400 
Internal 
coagulant 
External 
coagulant 
water 
water 
ethanol 
water 
water 
ethanol 
water 
water 
methanol 
water 
water 
methanol 
“spinning solution viscosity, bat T= 60’ C, “Lact = L-lactide. 
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TABLE 3 
Effect of spinning conditions on hollow fibre dimensions for spinning system H-146” 
Exp. Spinning height Extrusion rate Take-up rate Bore medium flow rate d,, d, d, 
no. (cm) (ml/min ) (m/min) (ml/h) Mn) (pm) (pm) 
1 1 0.5 1 20 800 600 100 
2 1 0.5 1 10 740 520 110 
3 1 1.5 3 30 750 540 105 
4 1 1.5 3 20 700 445 125 
5 1 1.5 3 40 800 570 115 
6 1 3.0 6 60 760 540 110 
7 1 3.0 6 80 800 590 105 
8 10 1.5 3 20 720 470 125 
9 10 1.5 3 40 740 500 120 
“spinning dope: PLLA/PVP/dioxane (see Table 2). d,,, d, and d, are outside diameter, inside diameter and wall thickness 
respectively. 
TABLE 4 
Effect of spinning conditions on hollow fibre dimensions for spinning system H-148 
Exp. Spinning height Extrusion rate Take-up rate Bore medium flow rate d,, di dw 
no. (cm) (ml/min) (m/min) (ml/h) W) Mn) (,um) 
1 1 1.5 3 30 620 460 80 
2 1 1.5 3 50 640 520 60 
3 1 2.4 3 50 800 600 100 
4 1 2.4 3 60 820 640 90 
5 1 2.4 4 60 720 580 70 
6 1 2.4 4 50 600 470 65 
7 10 2.4 4 50 780 590 95 
“Spinning dope: PLLA/PVP/CHCl, (see Table 2). 
ular spinning height used. Usually, the hollow 
fibre wall thickness was not influenced very 
much by variation of the bore medium flow rate. 
With increasing spinning solution extrusion 
rate, the hollow fibre inside and especially out- 
side diameter was increased, resulting in an 
increased wall thickness. When increasing the 
take-up rate (godet speed), a hollow fibre with 
smaller inside and outside diameter and smaller 
wall thickness was obtained. When increasing 
both the extrusion rate, take-up rate and bore 
medium flow rate simultaneously, a hollow fibre 
with the same dimensions was obtained. How- 
ever, if the bore medium flow rate was not 
increased simultaneously with the extrusion 
rate and take-up rate, a hollow fibre with smaller 
inside and outside diameter resulted. Variation 
of the spinning height did not show a straight- 
forward correlation with a change in hollow 
fibre dimensions. 
Hollow fibre membrane structure 
A number of hollow fibres were examined by 
SEM to investigate the structure of the hollow 
fibre wall. Representative macrostructures of 
PLLA hollow fibre cross-sections are shown in 
Figs. 2-4 for the products prepared by dry-wet 
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spinning of PLLA solutions in NMP (Fig. ‘2, 
spinning system H-144)) dioxane (Fig. 3, spin- 
ning system H-146) and chloroform (Fig. 4, 
spinning system H-148). The cross-sections in 
Figs. 2-4 show that hollow fibres with various 
wall structures are obtained. 
Typical membrane microstructures of the 
PLLA hollow fibres prepared using the differ- 
ent spinning systems investigated are shown in 
Figs. 5-10. The experimental preparation con- 
ditions and dimensions of the hollow fibre sam- 
ples examined are summarized in Table 5. 
Figure 11 shows that the porous sponge-like 
structured wall of the PLLA hollow fibre H-146- 
7 is covered by a dense external skin. A similar 
dense skin was also found to cover the internal 
surface of the hollow fibre wall (not shown). 
No SEM-observable pores were found in both 
the external and internal skin. 
Figures 12 and 13 show the structure of a 
porous wall covered by an internal skin (ca. 0.3 
Burn) and external skin (ca. 0.3-0.4pm), for fibre 
H-148-5. However, in this case the skins were 
not dense. Pores are found in both the internal 
surface (ca. 1-3 pm) and external surface (ea. 
0.2-0.5 pm). For the PLLA hollow fibres pre- 
pared using the different spinning systems ( see 
Tables 2 and 5), the thicknesses of the internal 
and external skins, and the diameters of the 
pores in the matrix of the wall are summarized 
in Table 6. 
Further characterization of PLLA hollow 
fibres 
PLLA hollow fibres obtained were also char- 
acterized with respect to average PLLA molec- 
ular weight, residual additive content, degree of 
PLLA crystallinity, glass transition and melt- 
ing temperature. Average PLLA molecular 
weight (M,, M,) determinations by GPC- 
LALLS of the hollow fibres prepared from 
PLLA-1 (see Table 2 ) showed that no polymer 
degradation had occurred during spinning of the 
dioxane and chloroform solutions. 
Viscometric analysis of the hollow fibres pre- 
Fig. 2. SEM micrograph of PLLA hollow fibre cross-sec- 
tion. Spinning dope: PLLAfNMP, IO/90 (wt.%). Spin- 
ning system H-144 (see Table 2). 
Fig. 3. SEM micrograph of PLLA hollow fibre cross-sec- 
tion. Spinning dope: PLLA/PVP/dioxane, 15/5/80 (wt.% 1. 
Spinning system H-146 (see Table 2). 
Fig. 4. SEM micrograph of PLLA hollow fibre cross-sec- 
tion. Spinning dope: PLLA/PVP/CHCl,, 1414.7181.3 
(wt.%). Spinning system H-146 (see Table 2). 
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Fig. 5. Cross-section of PLLA hollow fibre wall. Spinning 
dope: PLLA/NMP, lo/90 (wt.%). Spinning system: H-144- 
1 (see Table 5). Internal surface is facing up. 
Fig. 6. Cross-section of PLLA hollow fibre wall. Spinning 
dope: PLLA/dioxane, 15/85 (wt.% ) . Spinning system: H- 
145-4 (see Table 5 1. Internal surface is facing up. 
Fig. 8. Cross-section of PLLA hollow fibre wall. Spinning 
dope: PLLA/Lact/dioxane, 15/5/80 (wt.% 1. Spinning sys- 
tem: H-142-8 (see Table 5). Internal surface is facing up. 
Fig. 9. Cross section of PLLA hollow fibre wall. Spinning 
dope: PLLA/PVP/dioxane, 15/5/80 (wt.% 1. Spinning sys- 
tem: H-146-7 (see Table 5). Internal surface is facing to 
the left. 
Fig. 7. Cross-section of PLLA hollow tibre wall. Spmnmg 
dope: PLLA/CHCl:<, 14/86 (wt.% ) . Spinning system: H- 
147-1 (see Table 5). Internal surface is facing up. 
Fig. 10. Cross-section of PLLA hollow fibre wall. Spinning 
dope: PLLA/PVP/CHCl,, 14/4.7/81.3 (wt.% ) . Spinning 
system: H-185-5 (see Table 5). Internal surface is facing 
to the left. 
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TABLE 5 
Spinning conditions of hollow fibres examined by SEM” 
System 
code 
Spinning dopeb Spinning Extrusion Take-up Bore medium d, di d, 
height rate rate flow rate (pm) (pm) (pm) 
(cm) (ml/min) (m/min) (ml/h) 
H-144-3 PLLA/NMP 10 1.5 3.0 50 930 680 125 
H-145-4 PLLA/dioxane 10 1.5 4.5 40 630 530 50 
H-147-1 PLLA/CHC& 1 0.5 1.5 20 700 580 60 
H-142-8 PLLA/Lact/dioxane 0.5 0.5 1.0 20 720 620 50 
H-146-7 PLLA/PVP/dioxane 1 3.0 6.0 80 800 590 105 
H-148-5 PLLA/PVP/HCH& 1 2.4 4.0 60 720 580 70 
‘see also Table 2, bfor concentrations: see Table 2, ‘using PLLA-2. 
pared from the PLLA-2 solution in NMP (see 
Table 2), however, revealed that in this case 
significant polymer degradation had taken place 
during spinning. The PLLA intrinsic viscosity 
was reduced from 6.3 to 3.8 dlsg-‘, indicating a 
50% decrease in M,, i.e. from 4.7~ lo5 to 
2.4 x 105. 
‘H-NMR and infrared spectroscopic analysis 
of PLLA hollow fibres H-142-8, H-146-7 and 
H-148-5 (see Table 5) did not show the pres- 
ence of residual additive (L-lactide or PVP) in 
the hollow fibres, provided the samples had been 
thoroughly washed with non-solvent as 
described in the Experimental Section. This 
implies that the residual additive content of the 
hollow fibres was less than ca. 2.5 wt.%, being 
the additive detection limit of the methods used. 
The PLLA hollow fibres (H-145-4, H-147-1, 
H-146-7 and H-148-5) were analyzed by DSC 
measurements for their glass transition tem- 
perature ( !I’,), melting temperature ( T,) and 
degree of crystallinity. All samples examined 
showed a value of !I’, - 60’ C and T, - 176’ C, 
which are identical to the values commonly 
reported for PLLA [ 32,47,48]. No heat event 
attributable to the possible presence of PVP 
(Ref. 49: Tg - 100” C ) could be detected in the 
samples H-146-7 and H-148-5. All samples 
examined, including the ones prepared from a 
spinning solution containing PVP, showed a 
degree of crystallinity around 50%. The second 
DSC thermogram, recorded after the samples 
had been allowed to cool to room temperature, 
showed the same values for Tg and T, as found 
in the first scan. Slightly higher degrees of crys- 
tallinity (54-58%) were calculated from the 
second thermogram for all samples investigated. 
In vitro release of levonorgestrel 
The in vitro release of levonorgestrel from 
PLLA hollow fibres filled with a 25 wt.% dis- 
persion of micronized 3H-levonorgestrel in cas- 
tor oil was investigated, using a receiving fluid 
consisting of 40 wt.% aqueous ethanol 
(T=37”C). 
Figure 14 shows the plots of the cumulative 
amount of levonorgestrel released from the 
PLLA hollow fibres listed in Tables 5 and 6 as 
a function of time. The results show a very fast 
release of levonorgestrel from PLLA hollow 
fibre H-144-3 (spinning dope: PLLA/NMP) , 
which had released its total drug load within 3 
days. Only very small amounts of levonorges- 
trel were released from PLLA hollow fibres H- 
145-4 (spinning dope: PLLA/dioxane) , H-147- 
1 (spinning dope: PLLA/CHC13) and H-142-8 
(spinning dope: PLLA/Lact/dioxane) . These 
samples had released only ca. 3-5% of their drug 
load in 200 days (release rate ca. 0.1 
lug/cm/day ) . 
Constant (zero-order) intermediate release 
Fig. 11. External surface and wall cross-section at external 
surface of PLLA hollow fibre H-146-7. Spinning dope: 
PLLA/PVPfdioxane, 15/5/80 (wt.%). Spinning condi- 
tions: see Tables 2 and 5. 
rates were found for PLLA hollow fibres H-146- 
, 
/ 
7 and H-148-5. Samples H-146-7 (spinning 
dope: PLLA/PVP/dioxane) had released their 
I 
drug content in ca. 70 days, while samples H- 
148-5 (spinning dope: PLLA/PVP/CHCl,) still 
contained ca. 50% of their initial steroid load 
I after ca. 180 days. 
I Figure 15 and 16 show the daily amounts of 
levonorgestrel released from PLLA hollow 
fibres H-146-7 and H-148-5, respectively, which 
were calculated by dividing the amount of ste- 
roid measured in the receiving fluid by the 
duration of release since the last change of the 
g. mternal surrace e 
rface of PLLA hollow 
PLLA/PVP/CHCl,, 14/4.7/81.3 (wt.%). Spinning condi- 
tions: see Tables 2 and 5. 
Fig. 13. External surface and wall cross-section at externr 
----face of PLLA hollow fibre H-148-5. Spinning dopf 
PLLA/PVP/CHCI,, 14/4.76/81.3 (wt.%). Spinning car 
ditions: see Tables 2 and 5. 
receiving fluid. For PLLA hollow fibre H-146- 
7 ( spinning dope: PLLA/PVP/dioxane ) , a 
constant release rate of lo+- 1 pg/cm/day was 
found for a period of 60 days, after which the 
release rate rapidly decreased to zero within 
another lo-20 days (Fig. 15). For PLLA hol- 
low fibre H-148-5 (spinning dope: 
PLLA/PVP/CHCl,) , also a constant but much 
lower release rate was found, which amounted 
to 1.7 ? 0.2 pg/cm/day and continued up to the 
end of the release experiment, i.e. after ca. 180 
days (Fig. 16). In addition, to the release 
experiments described above, also the effect of 
gamma sterilization (2.5 MRad) of PLLA hol- 
low fibres (batch H-146-7)) before or after fill- 
ing with the steroid dispersion, on the hollow 
fibre release properties was investigated. GPC- 
LALLS measurements of the hollow fibre sam- 
ples which were gamma irradiated before filling 
indicated that PLLA average molecular weights 
were substantially decreased during gamma 
irradiation (i.e. from &,= 1.5~10~ and 
R;I,=9.5x104 to &,=5x104 and 
I&=2.5x104). 
31 
e: 
l- 
The results of the in vitro release experi- 
ments shown in Fig. 17, however, indicate that 
the release properties of these samples were not 
changed after gamma irradiation. An average 
levonorgestrel release rate of ca. 10 pg/cm/day 
was found, which is identical to that found for 
the non-irradiated samples (cf. Fig. 14). On the 
other hand, different release characteristics 
were found for the PLLA hollow fibre samples 
that were gamma irradiated after filling with the 
steroid dispersion. In this case a declining 
levonorgestrel release rate was found. Initially, 
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TABLE 6 
Pore diameters and skin thicknesses of PLLA hollow fibres” 
System 
code 
Spinning dope 
components cone. (wt.%) 
Matrix 
pore size” 
@m) 
Skin thicknessb (pm) 
internal external 
-~ ~_ 
H-144-3 PLLA/NMP 10/90 25 -50 ND ND 
H-145-4 PLLA~dio~ane X/85 l-3 2.5 co.5 
H-147-1 PLLA/CHCl, 14/86 0.5- 1 0.2 1 -2 
H-142-8 PLLA/Lact/dioxane 1515180 0.5- 2 1-2 0.5 
H-146-7 PLLA/PVP/dioxane 15/5/80 0.5- 5 0.2-0.3 0.3-0.4 
H-148-5 PLLA/PVP/CHCl:, 14/4.7/&X3 0.3- 8 0.3” 0.3-0.4” 
“for spinning conditions: see Tables 2 and 5, bestimated from SEM micrographs, ‘porous skin, ND: not determined. 
time (days) 
Fig. 14. Cumulative amount of levonorgestrel released iR 
uitro from PLLA hollow fibres (see Tables 5 and 6), filled 
with a 25 wt,% dispersion of 3H-levonorgestrel in castor oil, 
into a receiving fluid consisting of 40 wt.% aqueous ethanol 
maintained at 37°C. Each point represents the average value 
for five samples. 
a release rate of ca. 25 lug/cm/day was found, 
which decreased to ca. 10 fig/cm/day in a period 
of 30-40 days, and to even lower values 
thereafter. 
(ea. 4 iuglcmlday 1 was found compared to that 
using a receiving fluid consisting of 40 wt.% 
aqueous ethanol (cf. Fig. 14 and 17). 
Release experiments were also carried out The results of the irz vitro Ievonorgestrel 
with (non-sterilized) PLLA hollow fibres of release experiments from PLLA hollow fibres 
bath H-146-7 using a different receiving fluid are summarized in Tables 7 and 8. In Table 7 
composition, i.e. 25 wt.% aqueous ethanol. The also the (initial) steroid core loads of the hol- 
results represented in Fig. 17 show that in this low fibres are listed. The initial hollow fibre 
case a much lower levonorgestrel release rate levonorgestrel content was found to agree very 
time kIays) 
Fig. 15. Daily amounts of levonorgestrel released in vitro 
from PLLA hollow fibre H-146-7 (spinning dope: 
PLLA/PVP/dioxane; see Tables 5 and 6). Initial steroid 
content: 680 pg/cm. Each point represents the average value 
( F SD.) for five samples. For experimental data: see ieg- 
end of Fig. 14. 
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TABLE 7 
L’ ot-- -~ 
27 
T---~ -- -- -r-7- - 
0 80 120 160 
time (days) 
Fig. 16. Daily amounts of levonorgestrel released in oitro 
from PLLA hollow fibre H-148-5 (spinning dope: 
PLLA/PVP/CHCl,,; see Tables 5 and 6). Initial steroid 
content: 670 pg/cm. Each point represents the average value 
( + SD.) for five samples. For experimental data: see leg- 
end of Fig. 14. 
well with the steroid load calculated from the 
core volume of the hollow fibre and the density 
of the steroid dispersion (1.0 g/ml ) . 
In viva release of levonorgestrel 
The in uitro release properties of the hollow 
fibres used for the in uiuo experiments (rab- 
bits) are listed in Table 9. 
time (days) 
Fig. 17. Cumulative amount of levonorgestrel released in 
vitro from PLLA hollow fibre H-146-7 (for experimental 
data: see legend of Fig. 14) : (A) sample gamma irradiated 
(2.5 MRad) after filling ( 0); (B) sample gamma irradi- 
ated (2.5 MRad) before filling (0 ); (C) sample not irra- 
diated, receiving fluid 25 wt.% aqueous ethanol ( A ) . Each 
point represents the average value for three samples. 
In vitro release rates of levonorgestrel from PLLA hollow 
fibres” 
Batch 
code 
H-144-3 680 910 900 (300) 
H-145-4 530 550 540 0.10~0.05 
H-147-1 580 660 600 0.10~0.05 
H-142-8 620 775 760 0.15 + 0.05 
H-146-7 590 680 680 10.0 k. 1.0 
H-148-5 580 660 670 1.7f0.2 
Internal 
diameter 
(.um) 
Steroid load 
@g/cm ) 
calc.b found’ 
Levonorgestrel 
release rated 
(pg/cm/day) 
“for experimental conditions: see legend of Fig. 14, for data 
on hollow fibres: see Tables 5 and 6; bcalculated from core 
volume of hollow fibre and density of steroid dispersion 
( = 1.0 g/ml) ; ‘determined as described in Experimental 
Section; ‘average value ( t S.D.) for five samples. 
The results of the in. uiuo release experiments 
are represented in Fig. 18. The release of levon- 
orgestrel from PLLA hollow fibres H-146-8 
resulted in very constant blood plasma levels 
(ca. 0.2 ng/ml) for a period up to ca. 210 days. 
A very peculiar levonorgestrel blood level pro- 
file, however, was found for the rabbits 
implanted with PLLA hollow fibre H-149-4. 
After ca. 60 days, the steroid blood level 
TABLE 8 
In vitro levonorgestrel release rates from PLLA hollow fibre. 
H-146-7” 
Sample Levonorgestrel release 
rateb @g/cm/day) 
normal 
gamma irradiated before 
fillingd 
gamma irradiated after 
fillingd 
in 25 wt.% aqueous 
ethanol 
10 
10 
25-5 
4 
“for experimental conditions: see legend to Fig. 14 for data 
on hollow fibre: see Tables 5 and 6; baverage value for five, 
resp. three samples; non-irradiated, receiving fluid: 40 wt.% 
aqueous ethanol; ddose of 2.5 MRad (2.5 x lo4 m’/s*) . 
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TABLE 9 
PLLA hollow fibres used for in oiuo release experiments 
Batch Spinning dope 
code composition 
Outside 
diameter 
(pm) 
Inside 
diameter 
(pm) 
Steroid load 
(.kg/cm 1 
In vitro “H-levonorgestrel 
release rateC 
(pug/cm/day ) 
H-146-8 PLLA/PVP/dioxane” 720 470 435 10 +1 
H-149-4 PLLA/PVP/CHC& 840 575 645 2.5 + 0.2 
“identical to H-146-7; ‘identical to H-148-5 (see Tables 5 and 6); “experimental conditions: identical to as described above 
(see legend of Fig. 14). Average value ( + S.D.) for five samples. 
01 I, I II I I I ,I 
0 ICC :!a3 
time (days) 
Fig. 18. Daily rabbit blood plasma levels of levonorgestrel 
released from PLLA hollow fibres (L= 3 cm) filled with a 
25 wt.% dispersion of levonorgestrel in castor oil: 0 =H- 
146-8; 0 = H-149-4. Two devices were implanted into each 
rabbit. Each data point represents the average value 
( k SD.) for five samples. 
increased and thereafter remained reasonably 
constant for another 100 days at a value which 
was ca. 2 times that found for rabbits implanted 
with PLLA hollow fibres H-146-8. 
DISCUSSION 
Mechanism of membrane formation 
Dry-wet phase inversion spinning is a well- 
known method for obtaining hollow fibres with 
various isotropic or anisotropic membrane 
structures [ 501. In general, the mechanism of 
formation of hollow fibre membranes is closely 
related to that of flat-sheet membranes pro- 
duced by immersion precipitation [ 50,511. A 
model for the mechanism of formation of flat- 
sheet membranes by immersion precipitation 
which has recently been developed by Reuvers 
[ 52-551 will be used to qualitatively explain the 
membrane structure of PLLA fibres obtained 
by phase-inversion spinning using different 
conditions. Six different spinning dope com- 
positions were used for fabrication of the PLLA 
hollow fibres (see Table 3). 
The results presented in Tables 3 and 4 for 
two spinning systems (H-146 and H-148; see 
Table 2) show the effect of variation of some of 
the spinning parameters on the dimensions of 
the extruded hollow fibre. An increase in hol- 
low fibre dimensions was found in case of (a) 
an increase in bore medium flow rate (“blow- 
ing-up” of fibre from core), (b) an increase in 
spinning solution extrusion rate (predomi- 
nantly increasing the outside diameter and wall 
thickness), and (c) a decrease in the hollow 
fibre take-up rate. When increasing these three 
spinning parameters simultaneously and pro- 
portionally, the hollow fibre dimensions were 
found to remain constant. Similar effects of 
these spinning parameters on the dimensions 
of polysulfone hollow fibres spun from a solu- 
tion in N,N-dimethylacetamide (DMAc) con- 
taining PVP were reported by Cabasso et al. 
[561. 
Variation of the spinning height did not show 
a straightforward correlation with a change in 
hollow fibre dimensions. In a recent report on 
the dry-wet spinning of polysulfone hollow 
fibres from DMAc solutions containing PVP, 
Aptel et al. [ 571 could also not find a correla- 
tion between the spinning height and hollow 
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fibre dimensions. These authors suggested that 
an exact theoretical analysis of the dry-wet 
phase inversion spinning process would also 
have to take into account the die-swell phe- 
nomenon, which is the swelling of the extrudate 
as it emerges from a capillary, in order to explain 
the effect of the different spinning parameters 
on the hollow fibre dimensions [ 571. 
The effect of each of the six different spin- 
ning systems used on the PLLA hollow fibre 
membrane structure was investigated by SEM 
analysis of hollow fibre cross-sections (see 
Table 5 for samples investigated). 
Figures 5-10 show that in all cases a PLLA 
hollow fibre with an asymmetric membrane 
structure was obtained, consisting of a porous 
matrix covered by a more or less dense internal 
and external skin. Figures 2 and 5 show the wall 
structure of the hollow fibre spun from the 
PLLA solution in NMP (Table 6: system code 
H-144-3). The structure shows the presence of 
large macrovoids surrounded by very loosely 
connected material covered by a thin more 
dense internal and external skin. This indi- 
cates that at the internal as well as the external 
surface of the hollow fibre wall instantaneous 
onset of demixing caused by the high degree of 
miscibility of water and NMP occurs upon con- 
tacting the polymer solution with the coagulant 
[ 521. In addition to liquid-liquid phase sepa- 
ration in the matrix, probably also aggregates 
of PLLA were formed, PLLA being insoluble in 
NMP at temperatures below 50’ C. Aggregates 
are formed by nucleation and growth of the 
polymer-rich phase, which leads to a “porous” 
structure in which the dilute solvent/non-sol- 
vent forms the continuous phase [ 52,531. An 
indication that such aggregate formation 
occurred is obtained from the presence of the 
loosely connected material surrounding the 
macrovoids. The hollow fibre (code H-144-3) 
was mechanically very weak. Further charac- 
terization of the fibre showed that degradation 
of PLLA had taken place during spinning, 
resulting in a 50% reduction in I’&. Based on 
these findings, this spinning system using NMP 
as the solvent was considered unsuitable for the 
preparation of hollow fibres of the high molec- 
ular weight PLLA-2. 
Figure 6 shows the wall structure of the hol- 
low fibre spun from the PLLA solution in diox- 
ane (Table 5: system code H-145-4). In this 
case, a porous spongelike matrix, on both sides 
covered by a dense skin was found. A much 
thicker internal skin was observed as compared 
with the external skin (see also Table 6). This 
possibly could be caused by the fact that this 
hollow fibre was spun at a relatively large spin- 
ning height (10 cm; see Table 5 ) taking a longer 
time before the external surface of the nascent 
hollow fibre contacts the coagulant compared 
to the internal surface. During this period, some 
(internal) coagulant can penetrate from the 
bore towards the external surface [ 51 J. In 
addition, the external surface might pick up 
some moisture during passage through air. As a 
result, the external periphery already will con- 
tain some non-solvent when it contacts the 
coagulation bath. This promotes the onset of 
liquid-liquid demixing to be instantaneous upon 
contacting the external surface of the nascent 
hollow fibre with the water bath, resulting in a 
thin external skin [ 52 1. The thick internal skin 
might be a result of delayed onset of liq- 
uid-liquid demixing, because dioxane and water 
are only poorly miscible [ 521. 
Figure 7 shows the asymmetric wall structure 
of the hollow fibre spun from the PLLA solu- 
tion in chloroform (Table 5: system code H-147- 
1 ) , containing a very thin internal skin and a 
thicker external skin (see also Table 6). The 
presence of a thick external skin possibly 
resulted from evaporation of the highly volatile 
chloroform from the external surface of the 
nascent hollow fibre during passage through air. 
The solvent evaporation would increase the 
polymer concentration at the external surface, 
resulting in a thick toplayer. Use of an additive 
in the spinning dope will influence the mem- 
brane formation mechanism, as t,he phase 
inversion process is changed from a ternary to 
a quaternary system. For such a four-compo- 
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nent system containing two types of polymers, 
the phase inversion process is not yet fully 
understood [ 521. L-lactide was used as additive 
in the PLLA dioxane spinning solution (Table 
5: system code H-142-8). L-lactide dissolves in 
the polymer solvent (dioxane) and does not 
precipitate from this solution when contacted 
with the polymer nonsolvent (water). No 
residual L-lactide was found in the resulting 
PLLA hollow fibre. Substitution of part of the 
solvent for L-lactide did not have a very large 
effect on the structure of the resulting hollow 
fibre wall. A very similar membrane structure 
(Fig. 8) to that obtained when using the diox- 
ane solution without L-lactide was found (cf. 
Fig. 6)) with a somewhat thinner internal skin. 
Use of a low molecular weight water-soluble 
polymeric additive ( PVP, I&. = 104) however, 
did show a significant effect on the hollow fibre 
membrane structure. Substitution of part of the 
dioxane solvent in the spinning dope for PVP 
(Table 5: system code H-146-7) resulted in a 
PLLA hollow fibre wall structure (Figs. 9,ll) 
with a matrix containing larger interconnected 
pores and, especially for the internal surface, a 
much thinner skin (cf. Fig. 6). Still, both the 
internal and external skin appeared to be dense, 
with no SEM-observable pores (see e.g. Fig. 
11). However, it cannot be excluded that the 
skins contain very small pores not observed by 
SEM, i.e. smaller than ca. 5 x lo-” pm). Sub- 
stitution of part of the chloroform solvent in 
the spinning dope for PVP (Table 5: system 
code H-148-5) also resulted in a PLLA hollow 
fibre wall structure (Figs. 10, 12, 13) contain- 
ing larger pores in the matrix and, especially on 
the external surface in this case, a much thin- 
ner skin. However, both the internal and exter- 
nal skin were not dense, but obtained SEM- 
observable pores (Figs. 12 and 13). 
It should be noted that, although the PVP 
used was soluble in dioxane and chloroform (cf. 
Ref. 49)) a cloudy spinning dope was obtained 
on combining the PLLA and PVP dioxane or 
chloroform solutions. Possibly, interaction of 
PLLA and PVP by complex formation (see e.g. 
[ 49,581) caused the presence of PLLA-PVP 
aggregates in the spinning dope, which was 
found to have a decreased viscosity compared 
to the PLLA dioxane or chloroform solution 
without PVP (see Table 2: spinning system H- 
146 vs. H-145; H-148 vs. H-147). At this 
moment, however, it is not clear in what way 
the occurrence of this type of microphase sep- 
aration influences the hollow fibre membrane 
formation mechanism. 
Although no residual PVP was found in the 
resulting PLLA hollow fibres (sample code H- 
146-7, resp. H-148-5) and no difference in the 
DSC data was found between the samples spun 
in the absence or presence of PVP, it cannot be 
excluded that traces of PVP are present in the 
hollow fibre, entrapped between the PLLA seg- 
ments. However, the presence of small amounts 
of residual PVP will not cause a problem for 
possible use of the PLLA hollow fibre in con- 
trolled release applications. The low molecular 
weight PVP used (ti_,= 104) has molecular 
dimensions small enough to be excreted by the 
kidneys [ 491, is reported to be non-antigenic 
in man [ 591, and already is being used exten- 
sively for various applications in the pharma- 
ceutical and food industry [ 49,601. 
Levonorgestrel release rates from the hollow 
fibres 
For the PLLA hollow fibres used in this study, 
large differences in levonorgestrel release rates 
were found (see Table 7, and Fig. 14)) which 
were shown not to be caused by differences in 
hollow fibre dimensions. Therefore, the differ- 
ences in release rates must have resulted from 
variations in the PLLA hollow fibre membrane 
structures. The thicknesses of the internal and 
external skins of the PLLA hollow fibres, which 
were estimated from SEM micrographs of hol- 
low fibre cross-sections, together with the aver- 
age levonorgestrel release rates, are combined 
in Table 10. 
The very high release rate found for PLLA 
hollow fibre H-144-3 (spinning dope: 
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TABLE 10 
PLLA hollow fibre skin thicknesses” and levonorgestrel release rates 
Batch Spinning dope 
code composition 
Skin thickness (pm) Levo- 
norgestrel 
internal external release rate 
(Lcglcmlday) 
H-144-3 PLLA/NMP ND ND (300) 
H-145-4 PLLA/dioxane 2.5 < 0.5 0.10 
H-147-1 PLLA/CHCI., 0.2 1 -2 0.10 
H-142-8 PLLA/Lact/dioxane 1 -2 0.5 0.15 
H-146-7 PLLA/PVP/dioxane 0.2-0.3 0.3-0.4 10.0 
H-148-5 PLLA/PVP/CHCI., 0.3” 0.3-0.4h 1 
“average value; “porous skin; ND: not determined. 
PLLA/NMP) indicates that the hollow fibre 
membrane caused only very little or no diffu- 
sional resistance for levonorgestrel. Probably, 
the hollow fibre skins consisted of a highly 
porous and loosely connected structure. 
Obviously, this type of PLLA hollow fibre is 
unsuitable for long term controlled release 
applications for low molecular weight 
compounds. 
The very low levonorgestrel release rates of 
PLLA hollow fibres H-145-4 (spinning dope: 
PLLA/dioxane) , H-147-1 (spinning dope: 
PLLA/CHC&) and H-142-8 (spinning dope: 
PLLA/Lact/dioxane) probably are the result 
of the presence of a relatively thick and dense 
internal or external hollow tibre membrane skin 
(ca. 2 pm; see Table 10). Permeation of levo- 
norgestrel through the membrane skin may be 
of the solution-diffusion type. The low levon- 
orgestrel release rates for these hollow fibres 
would agree with such a mechanism, since 
PLLA is reported to have a very low permea- 
bility for steroids (e.g. [ 25,611) . 
As shown in Figs. 14 and 15, a constant (zero- 
order) and much higher levonorgestrel release 
rate was found for PLLA hollow fibre H-146-7 
(spinning dope: PLLA/PVP/dioxane) . The 
higher release rate, however, cannot only be 
explained by the smaller thickness of the hol- 
low fibre skin. Compared to PLLA hollow fibre 
H-145-4 (spinning dope: PLLA/dioxane) , for 
example, a hundred times higher steroid release 
rate was found for PLLA hollow fibre H-146-7, 
while in case of a membrane skin controlled 
permeation process only a ten times higher 
release rate would be expected on the basis of 
the ten times smaller skin thickness (see Table 
10). Although it is realized that estimations of 
hollow fibre skin thicknesses by SEM are not 
very accurate, it is not expected that this can 
explain the factor 10 difference. 
A 2.5 times lower levonorgestrel release rate 
from PLLA hollow fibre H-146-7 was found 
when using 25 wt. % aqueous ethanol instead of 
40 wt.% aqueous ethanol as the receiving fluid 
(see Fig. 17 and Table 8). One of the possible 
explanations for this result could be that in the 
solution-diffusion mechanism the steroid 
release rate is controlled by the rate of diffusion 
of the steroid from the hollow fibre into the 
receiving fluid (diffusion layer- limiting parti- 
tion-controlled process). In such a case, the 
release rate would be proportional to the solu- 
bility of the steroid in the receiving fluid. Table 
1 shows that the solubility of levonorgestrel in 
25 wt.% aqueous ethanol is about half of that in 
40 wt.% aqueous ethanol. This agrees very well 
with the difference in release rates, especially 
when considering that the method used to 
determine the steroid solubilities only gives a 
rough estimation. A method to investigate 
whether the release is controlled by a boundary 
layer-limiting diffusion process is to increase the 
agitation intensity of the receiving fluid [ 40,561. 
However, increasing the water bath shaking 
frequency (from 135 to 190 cycles/min) in this 
study did not change the steroid release rates. 
Therefore, a diffusion layer-limiting partition- 
controlled release mechanism is considered not 
very likely for PLLA hollow fibre H-146-7. 
Instead, a pore-diffusion mechanism could be 
operative for release from PLLA hollow fibre 
H-146-7, in which the steroid release rate is 
controlled by the partitioning of the steroid from 
the core vehicle into the receiving fluid in the 
pores of the membrane skin. This mechanism 
also would account for the dependence of the 
release rate on the steroid solubility in the 
receiving fluid observed. The presence of pores 
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in the skins of this type of PLLA hollow fibre 
is not very unlikely, since the hollow fibre was 
spun from a spinning dope containing PVP. Use 
of PVP as an additive in the spinning dope is a 
well-known method for preparing hollow fibres 
with microporous skins [ 51,571. The fact that 
no SEM-observable pores were found in the 
skins of PLLA hollow fibre H-146-7 indicates 
that, if pores are present, they are smaller than 
ca. 5 x lop3 pm, which is the detection limit of 
the SEM method used. Such pores could still be 
large enough for diffusion of the small steroid 
molecules, which have a minimal cross-sec- 
tional area of ca. 40 A” [ 621. 
Figures 14 and 16 show that also for PLLA 
hollow fibre H-148-5 (spinning dope: 
PLAA/PVP/CHCl,) a constant levonorgestrel 
release rate was found, which however was lower 
than that for follow fibre H-146-7 (see Table 
10). In this case, the steroid release rate prob- 
ably will not be determined by the permeability 
of the hollow fibre membrane skins, which were 
found (see Figs. 12 and 13) to contain SEM- 
observable pores ( > 0.1 pm). More likely, the 
release rate will be mainly controlled by the rate 
of steroid diffusion through the hollow fibre 
matrix, which was found to contain pores show- 
ing only a limited degree of interconnection. In 
this case, a pore-diffusion mechanism can also 
be imagined, in which the lower levonorgestrel 
release rate compared to that of hollow fibre H- 
146-7 could be explained by the larger part of 
the membrane thickness showing hindered dif- 
fusion and the increased tortuosity. The results 
obtained in this explorative study show that the 
PLLA hollow fibre levonorgestrel release rates 
could be varied over a wide range (i.e. 0.1-10 
pg/cm/day) by variation of the hollow fibre 
spinning conditions. 
Of the different PLLA hollow fibres investi- 
gated (excluding sample H-144-3)) the highest 
(zero-order) levonorgestrel release rates were 
found for the samples that were prepared using 
a spinning dope containing PVP as an additive 
(H-146-7, H-148-5). The results of the in vitro 
levonorgestrel release experiments suggest that 
these higher release rates might be the result of 
a change in release mechanism from a solution- 
diffusion type through the skin for the samples 
spun in the absence of PVP to a pore-diffusion 
type for the ones prepared in the presence of 
PVP. However, more experiments are neces- 
sary to verify this hypothesis. 
The possible use of the PLLA hollow fibre 
device as a long-acting contraceptive deliv- 
ery system 
Assuming a constant levonorgestrel release 
rate for PLLA hollow fibre H-146-8, an average 
in uiuo release rate of 2 yg/cm/day is calculated 
for this type of PLLA hollow fibre by dividing 
the initial steroid load (435 pg/cm) by the 
duration of release ( 210 days) (Fig. 18). This 
value is one fifth of that found for the in vitro 
release rate ( see Table 9 ) . As already discussed 
above, the in vitro levonorgestrel release rate 
from this type of PLLA hollow fibre (H-146-7) 
was found to be dependent on the steroid solu- 
bility in the surrounding receiving fluid (see Fig. 
17 and Table 8). The fact that in uiuo a lower 
release rate was found might therefore be 
explained by the lower solubility of levonorges- 
trel in the fluid surrounding the hollow fibre in 
uiuo than in the 40 wt.% aqueous ethanol used 
as receiving fluid in the in vitro release 
experiments. 
Based on these results, it appears necessary 
to increase the in uiuo levonorgestrel release rate 
by a factor 5 to obtain a value of ca. 10 
pg/cm/day (i.e. a device of 3 cm length releas- 
ing 30 pg/day ) . This could be accomplished in 
part by increasing the hollow fibre dimensions 
by a factor 2 to an outer diameter of ca. 1.5 mm 
and inner diameter of ca. 1.0 mm, which would 
increase the steroid release rate by a factor 2. 
Further increase of the steroid release rate pos- 
sibly can be accomplished by variation of the 
spinning conditions to influence the structure 
of the hollow fibre membrane. Increasing the 
hollow fibre dimensions will also increase the 
duration of release. A device with an inner 
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diameter of 1.0 mm, filled with a 25 wt.% dis- 
persion of levonorgestrel in castor oil, will con- 
tain enough steroid (ca. 2 mg/cm) to release 10 
pg/cm per day for a period of 6 months. Further 
increase of the duration of release, if desired, 
could then be accomplished by increasing the 
concentration of levonorgestrel in the core 
vehicle. 
An important aspect in the development of 
the hollow fibre controlled release device is the 
method of sterilization. In this study, steriliza- 
tion of PLLA hollow fibres (H-146-7) by 
gamma irradiation (2.5 MRad) after filling with 
the levonorgestrel dispersion in castor oil was 
found to have a significant effect on the steroid 
release rate (see Fig. 17 and Table 8). An ini- 
tially much higher and thereafter declining rate 
of steroid release was found for the sterilized 
devices. An explanation for these phenomena, 
however, is not available at this moment. Pos- 
sibly, an adverse effect of the gamma radiation 
on levonorgestrel could be involved [63,64]. 
Also, an effect of the sterilization method on 
the castor oil can not be excluded. In contrast, 
the release properties of the PLLA hollow fibres 
that were gamma irradiated before filling were 
not changed (see Fig. 17). This implies that 
gamma sterilization of the empty PLLA hollow 
fibres, followed by filling under aseptic condi- 
tions, could be a possible method to obtain ster- 
ile devices. 
The useful lifetime of this new device will be 
determined by the in uiuo degradation rate of 
the PLLA hollow fibres. PLLA usually is con- 
sidered to be a very slowly degrading material 
[ 27-291, with reported in vivo degradation 
times up to 4 years [ 651. It should be noted, 
however, that the actual degradation rate of the 
PLLA hollow fibre device will depend on the 
polymer molecular weight, degree of crystallin- 
ity, size and shape of the device, and especially 
its porosity, in addition to the particular animal 
species and implantation site used [ 29,66 ] . The 
in viuo rate of degradation of the hollow fibres 
as well as the histocompatibility are currently 
investigated. 
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